Sialorrhea is the medical term for excessive drooling, meaning saliva spills beyond the lip margin in amounts that go well past what’s normal. It can result from the body producing too much saliva or, more commonly, from an inability to manage and swallow saliva effectively. While drooling is perfectly normal in infants, persistent sialorrhea in older children and adults typically signals an underlying neurological condition or a medication side effect.
Why Sialorrhea Happens
There are two broad paths to sialorrhea. The first is genuine overproduction of saliva, which is less common and usually triggered by medications or, rarely, has no identifiable cause. The second, and far more frequent, path is a breakdown in the body’s ability to clear saliva from the mouth. Normally, the muscles of your face, tongue, and palate work together in a coordinated sequence that moves saliva toward the back of the throat and triggers a swallow. When neurological disease disrupts that coordination, saliva pools in the front of the mouth and eventually spills out.
This distinction matters because it shapes treatment. Someone whose salivary glands are simply overactive needs a different approach than someone whose swallowing reflex isn’t firing properly, even though the visible symptom looks the same.
Conditions Linked to Sialorrhea
Sialorrhea shows up across a range of neurological conditions. In Parkinson’s disease, reported rates vary widely, from 10% to 81% of patients, depending on disease stage and how drooling is measured. Among people with ALS (amyotrophic lateral sclerosis), 22% to 50% experience it. In children with cerebral palsy, the prevalence falls between 22% and 40%.
In all three of these conditions, the core problem is impaired neuromuscular function. The brain’s signals to the muscles involved in swallowing become weaker, slower, or poorly timed. Stroke, traumatic brain injury, and certain developmental disabilities can produce the same effect.
Medications are the other major cause. Clozapine, an antipsychotic used when other medications for schizophrenia haven’t worked, is the most well-known culprit. Between 30% and 80% of people taking clozapine develop hypersalivation, sometimes in large, socially disruptive quantities. Other drugs that act on the nervous system can also increase saliva production, though clozapine is by far the most commonly reported.
Physical and Social Consequences
Sialorrhea is far more than an inconvenience. Physically, constant moisture around the mouth and chin leads to skin irritation and chapping. Over time the skin can break down, becoming raw and painful. The saliva itself can develop an unpleasant odor, and in severe cases, the sheer volume of fluid lost through drooling contributes to dehydration.
The more dangerous complication is aspiration. When saliva pools in the throat rather than being swallowed cleanly, it can trickle into the airway and lungs. Repeated aspiration raises the risk of pneumonia, a potentially life-threatening concern for people already weakened by neurological disease.
The psychosocial toll is equally serious. Visible drooling carries significant social stigma. It can lead to isolation, embarrassment, and withdrawal from daily activities, affecting not just patients but their families and caregivers. For children in school settings, the impact on peer relationships and self-esteem can be profound.
How Sialorrhea Is Measured
Clinicians often use the Drooling Severity and Frequency Scale (DSFS) to gauge how bad the problem is. It’s a simple two-question tool. The first question rates severity on a 1 to 5 scale, from “never drools” to “profuse.” The second rates frequency on a 1 to 4 scale, from “no drooling” to “constant.” The two scores are added together for a combined drooling score ranging from 2 to 9. This gives a standardized way to track whether treatment is actually helping over time.
Behavioral and Therapy Approaches
The least invasive starting point is speech therapy focused on oral motor skills. A therapist works on strengthening the muscles of the lips, tongue, and jaw while improving sensory awareness inside the mouth. The goal is to help the person recognize when saliva is accumulating and trigger a swallow before drooling occurs. Postural adjustments, like correcting head position to keep the chin slightly tucked, can reduce the tendency for saliva to flow forward.
Behavioral strategies are particularly useful in children. These include prompting (reminders to swallow), positive reinforcement for dry periods, and structured practice routines. Research in children with cerebral palsy has shown that speech therapy works best when combined with other treatments rather than used alone.
Medication Options
When behavioral strategies aren’t enough, anticholinergic medications are the standard next step. These drugs work by blocking the nerve signals that tell salivary glands to produce saliva. The most commonly used options include glycopyrrolate, scopolamine, atropine, and trihexyphenidyl.
Glycopyrrolate in oral solution form is approved in some countries specifically for chronic severe drooling in children ages 3 to 18 with neurological conditions like cerebral palsy. Dosing is based on body weight and taken after meals, with gradual increases over several weeks until the right balance is found between saliva reduction and side effects. Common side effects of anticholinergics include dry mouth (which, ironically, is the goal taken too far), constipation, and urinary retention.
For clozapine-induced sialorrhea specifically, antimuscarinic medications have been the most studied, though managing this side effect often requires careful coordination with a prescriber to avoid interfering with the psychiatric medication.
Botulinum Toxin Injections
Botulinum toxin, injected directly into the salivary glands, offers a middle ground between medication and surgery. The toxin temporarily blocks the nerve signals that drive saliva production in the targeted gland. It’s most commonly injected into the submandibular glands, which sit beneath the jaw and produce the majority of resting saliva.
A study of 131 children found that botulinum toxin was effective in roughly half of patients, with a median duration of about 22 weeks (around five months) before symptoms returned. That means repeat injections are necessary to maintain the benefit, typically two to three times per year. The procedure is relatively quick but may require sedation in children or patients who have difficulty staying still.
Surgical Options for Severe Cases
When conservative treatments and injections fail to control sialorrhea, surgery becomes an option. The most common procedure is removal of the submandibular glands, sometimes combined with rerouting or tying off the ducts of the parotid glands (the large salivary glands near the ears). A systematic review of over 700 patients found consistently positive outcomes with gland removal alone. Adding parotid duct procedures at the same time did not appear to provide additional benefit.
Surgery is typically reserved for patients with chronic, severe sialorrhea that hasn’t responded to other treatments. It permanently reduces saliva volume, which is both its advantage and its tradeoff: some patients experience excessive dryness afterward, which can affect dental health and comfort.